Showing results (101-110 of 340) with videos related to

Sort By:
Pageof 34
Antiviral Research|November 26, 2009
Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patientsChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 7, 2019
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basisJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
Journal of Gastroenterology and Hepatology|July 5, 2022
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in TaiwanChih-Lin Lin, Chi-Ming Tai, Jee-Fu Huang, et al.
Plos One|January 29, 2021
The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in TaiwanYing-Chou Huang, Chung-Feng Huang, Shu-Fen Liu, et al.
The Kaohsiung Journal of Medical Sciences|February 9, 2012
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patientsMing-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences|April 30, 2020
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatmentZu-Yau Lin, Jing-Houng Wang, Ming-Lun Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2016
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of TreatmentMing-Lung Yu, Chung-Feng Huang, Ming-Lun Yeh, et al.
Scientific Reports|October 27, 2018
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resectionChung-Feng Huang, Shu-Chi Wang, Wen-Tsan Chang, et al.
Antiviral Therapy|February 17, 2007
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapyMing-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre studyChia-Yen Dai, Tai-Chung Tseng, Grace Lai Hung Wong, et al.
Pageof 34